MedTrace Logo

Integrative Therapy of Chronic Diseases

NCT04927403 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-02-01

No results posted yet for this study

Summary

The observational study aims to investigate the extent to which a two-week stay in an internal medicine clinic for integrative medicine and naturopathy results in an improvement of complaints, impairments, quality of life, anxiety/depressiveness, stress perception and well-being in chronic gastroenterological patients and chronic rheumatological/pain patients. In addition, previous experiences with complementary naturopathic procedures, expectations of treatment, perceived benefits and implementation of instructed techniques and procedures in everyday life will be investigated.

Since May 2021, patients with Post Covid-19 Syndrome have been treated as inpatients during a stay that usually lasts 14 days. Since January 2022 these patients are evaluated in the substudy "StaPoCo". Since 2022 Post Covid-19 Syndrome day clinic patients were also evaluated.

Sub-Study "Intestinal barrier dysfunction" - Gastroenterological patients who undergo routine gastroscopy and/or colonoscopy with confocal laser endomicroscopy (cLE) and tissue biopsies at the beginning of their inpatient stay are explicitly examined for the presence of a barrier disorder.

Since May 2021 patients can take part in the day clinic programme one day weekly for ten or eleven weeks. In this programme also patients with oncological disorders take part.

Starting in the fall of 2022, the integrative medicine/naturopathic day clinics at the Immanuel Hospital in Berlin and the Ev. Kliniken Essen-Mitte will be included in the evaluation.

Conditions

Interventions

OTHER

multimodal integrative naturopathic therapy concept

Use of conventional medicine, naturopathic approaches and complementary medical therapy methods

Sponsors & Collaborators

  • Sozialstiftung Bamberg

    collaborator OTHER

  • Bavarian State Ministry of Health and Care

    collaborator OTHER_GOV

  • Charite University, Berlin, Germany

    collaborator OTHER

  • Kliniken Essen-Mitte

    collaborator OTHER

  • Universität Duisburg-Essen

    lead OTHER

Principal Investigators

  • Jost Langhorst, Prof. · Sozialstiftung Bamberg, Klinik für Integrative Medizin und Naturheilkunde

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-04
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04927403 on ClinicalTrials.gov